Sort
39,280 grants matching “leukemia”
CORE II - Genetics & Informatics Using Statistics CORE (GENIUS)
$687,904Nancy J. Cox · University Of Chicago · U01 · FY2010 · GM
Novel CRISPR-Cas9 protein delivery to T cells in vivo by targeting CD7
$687,900Guohua Yi · University Of Texas Hlth Ctr At Tyler · UG3 · FY2020 · AI
Defining Genome Stability Mechanisms and their Regulation by SUMO and Ubiquitin
$687,800Michael Nicholas Boddy · Scripps Research Institute, The · R35 · FY2023 · GM
Protein Tyrosine Dephosphorylation & Signal Transduction
$687,770Nicholas K Tonks · Cold Spring Harbor Laboratory · R01 · FY2011 · CA
Gene Transfer into Hematopoietic Stem Cells
$687,764Fabio Candotti · National Human Genome Research Institute · ZIA · FY2010 · HG
Clinical Cancer Cytogenetics
$687,607Diane C Arthur · Division Of Basic Sciences - Nci · ZID · FY2009 · CA
The role of inflammation in driving leukemogenesis in germline predisposition syndromes
$687,587Lucy Ann Godley · Northwestern University At Chicago · U01 · FY2023 · CA
Towards an inclusive genomic risk classification for acute myeloid leukemia (AML)
$687,428Ann-Kathrin Eisfeld · Ohio State University · R01 · FY2023 · CA
ITSC for Leukemia: Novel Molecular Strategies for NCTN: "Individualized" Therapie
$687,345Clara D Bloomfield · Ohio State University · U10 · FY2016 · CA
Molecular Phenotypes for Lung Diseases
$687,318David Brian Corry · Baylor College Of Medicine · R01 · FY2011 · HL
Conformal Total Body and Marrow Irradiation for Leukemia
$687,213Susanta K Hui · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Mechanisms of Transformation by TAL1/SCL in Thymic Malignancy
$687,030A Thomas Look · Dana-Farber Cancer Inst · P01 · FY2011 · CA
Targeting obesity to improve survival from childhood acute lymphoblastic leukemia
$687,010Etan Orgel · Children'S Hospital Of Los Angeles · R37 · FY2021 · CA
Development of Inhibitors of the Leukemia Fusion Protein CBFbeta-SMMHC
$686,873John Hackett Bushweller · University Of Virginia · R01 · FY2010 · CA
An Automated Platform for Kinase Assays on Patient Cells
$686,866University Of California Irvine · R01 · FY2005 · EB
Predictors of Myelodysplastic Syndrome in Minnesota
$686,590Jenny N. Poynter · University Of Minnesota · R01 · FY2020 · CA
Modulation of T cell Homeostasis in Myelodysplastic Syndrome (MDS)
$686,377Pearlie K Epling-Burnette · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2009 · CA
Predictors of Myelodysplastic Syndrome in Minnesota
$686,302Jenny N. Poynter · University Of Minnesota · R01 · FY2021 · CA
Rochester Network Lead Academic Participating Site
$686,279Paul M Barr · University Of Rochester · UG1 · FY2022 · CA
Rochester Network Lead Academic Participating Site
$686,279Paul M Barr · University Of Rochester · UG1 · FY2019 · CA
Rochester Network Lead Academic Participating Site
$686,279Paul M Barr · University Of Rochester · UG1 · FY2020 · CA
Novel Approaches to CD33-Directed Radioimmunotherapy
$686,273Roland Bruno Walter · Fred Hutchinson Cancer Research Center · R37 · FY2020 · CA
RUNX1-mediated regulation of MEP fate specification
$686,113Diane S. Krause · Yale University · R01 · FY2025 · DK
Development of Potent, Selective, Non-Myelotoxic FLT3 Inhibitors that Retain Efficacy Against Common Mechanisms of Resistance
$685,777Neil P Shah · University Of California, San Francisco · R01 · FY2021 · CA
Training Program in Molecular Hematology
$685,736Nancy Berliner · Brigham And Women'S Hospital · T32 · FY2022 · HL